Agenus reported $10.06M in Gross Profit on Sales for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Amgen AMGN:US $ 5097M 208M
AstraZeneca AZN:LN 6.04B 15M
Bristol Myers Squibb BMY:US $ 9333M 81M
CSL CSL:AU $ 2.37B 1.1B
Eli Lilly And LLY:US $ 5342M 555.1M
Flexion Therapeutics FLXN:US $ 17.6M 5.6M
Gilead Sciences GILD:US $ 6198M 1371M
GlaxoSmithKline GSK:LN 6.26B 682M
Glaxosmithkline GSK:US $ 6255M 682M
Jiangsu Hengrui Me. 600276:CH CH 5.88B 399.7M
Johnson & Johnson JNJ:US $ 16088M 343M
Karyopharm Therapeutics KPTI:US $ 37.1M 15.64M
MacroGenics MGNX:US 14M 16.74M
Merck MRK:GR € 3114M 57M
Merk MRK:US $ 10098M 1738M
Novartis NOVN:VX 9.52B 21M
Pfizer PFE:US $ 14163M 2178M
Regeneron Pharmaceuticals REGN:US $ 2999.6M 1445.2M
Rigel Pharmaceuticals RIGL:US $ 21.39M 4.74M
Veracyte VCYT:US $ 38.73M 1.09M
YTE INCY:US $ 778.52M 105.44M